Basilea shareholders approve all proposals of the board of
Basel/Allschwil, Switzerland, April 26, 2023 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to...
Stay updated with breaking news from Thomas Werner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Basel/Allschwil, Switzerland, April 26, 2023 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to...
Basel/Allschwil, Switzerland, April 26, 2023 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial or
Basel/Allschwil, Switzerland, April 26, 2023 Basilea Pharmaceutica Ltd , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial or... | June 18, 2023
22% year-on-year increase of royalty income from antifungal Cresemba®Operating profit of CHF 18.5 million and net profit of CHF 12.1 millionStrengthened balance sheet through non-dilutive repayment of
LeBron James, you've said that fans in Boston are racist. I'm here to tell you it's more complicated than that.